Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.11.007
Yuwei Ma , Yaning Fu , Ge Bai , Shancen Zhao , Ya Tian , Ziyuan Zhao , Yan Wang , Zhichao Xu , Yong Chen , Zhoujie An , Ranran Gao
Objective
Benzylisoquinoline alkaloids (BIAs) are valuable plant metabolites whose structural diversity largely depends on O-/N-methyltransferases (OMTs/NMTs). Although the CYP450-mediated backbone formation of BIAs was previously elucidated in Menispermum dauricum DC., the specific OMTs/NMTs responsible for their functional methylation remain unknown. This study aims to systematically identify and characterize these methyltransferases to define their roles in BIA biosynthesis.
Methods
Combining genomic and biochemical approaches, a genome-wide identification of methyltransferase (MT) genes was conducted using the published M. dauricum genome. The candidate MTs were functionally evaluated through in vitro enzymatic assays employing diverse BIA substrates to determine their methylation specificities. The substrate-binding modes of MdOMT1 and MdOMT11 were predicted and compared by protein modeling and molecular docking.
Results
Functional characterization of the 75 methyltransferases identified in the M. dauricum genome revealed four key enzymes (three OMTs and one NMT) that contribute to the diversification of BIA scaffolds through their distinct substrate specificities and positional preferences. Specifically, MdOMT1 preferentially catalyzed O-methylation at C7 position of 1-benzylisoquinolines (1-BIAs) and C2 position of tetrahydroprotoberberines. In contrast, MdOMT11 exhibited superior affinity and a strong preference for O-methylation at the C9 position of (S)-scoulerine. Meanwhile, MdNMT3 demonstrated effective N-methylation activity toward both 1-BIAs and tetrahydroprotoberberines.
Conclusion
This research elucidates the functional landscape of OMTs/NMTs in M. dauricum, revealing their crucial roles in BIA structural diversification. The newly identified enzymes provide valuable biocatalytic tools for synthetic biology approaches aimed at the sustainable and optimized production of high-value BIAs.
目的苯基异喹啉生物碱(BIAs)是一种有价值的植物代谢物,其结构多样性主要取决于O-/ n -甲基转移酶(OMTs/NMTs)。尽管cyp450介导的偏倚主干形成先前已在半月草DC中被阐明。,负责其功能性甲基化的特定omt / nmt仍然未知。本研究旨在系统地鉴定和表征这些甲基转移酶,以确定它们在BIA生物合成中的作用。方法采用基因组学和生物化学相结合的方法,利用已发表的稻壳菌基因组对甲基转移酶(MT)基因进行全基因组鉴定。候选MTs通过使用不同BIA底物的体外酶分析来评估其功能,以确定其甲基化特异性。通过蛋白建模和分子对接对MdOMT1和MdOMT11的底物结合模式进行了预测和比较。结果通过对75种甲基转移酶的功能分析,揭示了4种关键酶(3种omt和1种NMT)通过其不同的底物特异性和位置偏好促进BIA支架的多样化。具体来说,MdOMT1优先催化1-苄基异喹啉(1-BIAs)的C7位点和四氢原小檗碱的C2位点的o -甲基化。相比之下,MdOMT11在(S)-scoulerine的C9位置表现出更强的亲和力和对o -甲基化的强烈偏好。同时,MdNMT3对1-BIAs和四氢原小檗碱均表现出有效的n -甲基化活性。结论本研究阐明了M. dauricum中OMTs/NMTs的功能格局,揭示了它们在BIA结构多样化中的重要作用。新发现的酶为合成生物学方法提供了有价值的生物催化工具,旨在可持续和优化生产高价值的BIAs。
{"title":"Genome-wide identification and characterization of methyltransferase involved in benzylisoquinoline alkaloids biosynthesis from Menispermum dauricum","authors":"Yuwei Ma , Yaning Fu , Ge Bai , Shancen Zhao , Ya Tian , Ziyuan Zhao , Yan Wang , Zhichao Xu , Yong Chen , Zhoujie An , Ranran Gao","doi":"10.1016/j.chmed.2025.11.007","DOIUrl":"10.1016/j.chmed.2025.11.007","url":null,"abstract":"<div><h3>Objective</h3><div>Benzylisoquinoline alkaloids (BIAs) are valuable plant metabolites whose structural diversity largely depends on <em>O</em>-/<em>N</em>-methyltransferases (OMTs/NMTs). Although the CYP450-mediated backbone formation of BIAs was previously elucidated in <em>Menispermum dauricum</em> DC., the specific OMTs/NMTs responsible for their functional methylation remain unknown. This study aims to systematically identify and characterize these methyltransferases to define their roles in BIA biosynthesis.</div></div><div><h3>Methods</h3><div>Combining genomic and biochemical approaches, a genome-wide identification of methyltransferase (MT) genes was conducted using the published<!--> <em>M. dauricum</em> <!-->genome. The candidate MTs were functionally evaluated through <em>in vitro</em> enzymatic assays employing diverse BIA substrates to determine their methylation specificities. The substrate-binding modes of MdOMT1 and MdOMT11 were predicted and compared by protein modeling and molecular docking.</div></div><div><h3>Results</h3><div>Functional characterization of the 75 methyltransferases identified in the <em>M. dauricum</em> genome revealed four key enzymes (three OMTs and one NMT) that contribute to the diversification of BIA scaffolds through their distinct substrate specificities and positional preferences. Specifically, MdOMT1 preferentially catalyzed <em>O</em>-methylation at C7 position of 1-benzylisoquinolines (1-BIAs) and C2 position of tetrahydroprotoberberines. In contrast, MdOMT11 exhibited superior affinity and a strong preference for <em>O</em>-methylation at the C9 position of (<em>S</em>)-scoulerine. Meanwhile, MdNMT3 demonstrated effective <em>N</em>-methylation activity toward both 1-BIAs and tetrahydroprotoberberines.</div></div><div><h3>Conclusion</h3><div>This research elucidates the functional landscape of OMTs/NMTs in <em>M. dauricum</em>, revealing their crucial roles in BIA structural diversification. The newly identified enzymes provide valuable biocatalytic tools for synthetic biology approaches aimed at the sustainable and optimized production of high-value BIAs.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 97-109"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.05.005
Jun Li , Xuewen Zhu , Yupeng Du , Wenxiao Chen , Jing Xu , Ying Wang , Shasha Zhou , Zhichao Xu , Shuangcheng Ma , Zhenhao Li , Wei Sun , Yaolei Mi
Objective
The basic helix-loop-helix (bHLH) transcription factors (TFs) are pivotal in regulating fungal growth, development, and secondary metabolism. However, the knowledge about the Ganoderma lucidum bHLHs (GlbHLHs) in ganoderic acid (GA) biosynthesis of G. lucidum was limited. This study aimed to explore the functions of bHLH genes in ganoderic acid biosynthesis during G. lucidum growth development.
Methods
First, the genome-wide identification of GlbHLHs was performed through Hidden Markov model searches and Two-way blast. Furthermore, through physicochemical properties, gene structure, and phylogenetic analysis, as well as combining the transcriptome and metabolome data from different developmental stages of G. lucidum, candidate GlbHLHs were screened. Subsequently, their regulatory roles in ganoderic acid biosynthesis were explored using yeast one-hybrid and dual-luciferase reporter assays.
Results
A total of 11 GlbHLH members were characterized in G. lucidum. The upstream promoter regions of these genes enriched hormones and abiotic stress responsive elements. Although individual ganoderic acid monomers demonstrated marked differences in accumulation patterns across specific growth phases and tissue types, overall, the total GA content was consistently higher in caps than in stipes throughout development. In addition, all GlbHLHs exhibited high expression in whole G. lucidum from the primordium to maturation stages. Among them, GlbHLH5 and GlbHLH7 showed the highest expression in any stage and highly correlated with key genes associated with GA pathway. Functional validation through dual-luciferase assays and yeast one-hybrid experiments had demonstrated that GlbHLH5 activated the P2 region of the lanosterol synthase promoter, while GlbHLH7 activated the promoters of squalene epoxidase and squalene synthase.
Conclusion
Compared to plants, G. lucidum harbored a small number of bHLH members but all high expression in any stages. Additionally, GlbHLH5 and GlbHLH7 with the highest expression among GlbHLHs showed activation in regulating the biosynthesis of GA. These results provide a theoretical reference for further research on ganoderic acid regulation in G. lucidum, and thereby providing a molecular foundation for enhancing ganoderic acid yield to optimize the medicinal value of G. lucidum.
{"title":"Comprehensive genomic identification and functional analysis of bHLH transcription factors in Ganoderma lucidum","authors":"Jun Li , Xuewen Zhu , Yupeng Du , Wenxiao Chen , Jing Xu , Ying Wang , Shasha Zhou , Zhichao Xu , Shuangcheng Ma , Zhenhao Li , Wei Sun , Yaolei Mi","doi":"10.1016/j.chmed.2025.05.005","DOIUrl":"10.1016/j.chmed.2025.05.005","url":null,"abstract":"<div><h3>Objective</h3><div>The basic helix-loop-helix (<em>bHLH</em>) transcription factors (TFs) are pivotal in regulating fungal growth, development, and secondary metabolism. However, the knowledge about the <em>Ganoderma lucidum bHLHs</em> (<em>GlbHLHs</em>) in ganoderic acid (GA) biosynthesis of <em>G</em>. <em>lucidum</em> was limited. This study aimed to explore the functions of <em>bHLH</em> genes in ganoderic acid biosynthesis during <em>G. lucidum</em> growth development.</div></div><div><h3>Methods</h3><div>First, the genome-wide identification of <em>GlbHLHs</em> was performed through Hidden Markov model searches and Two-way blast. Furthermore, through physicochemical properties, gene structure, and phylogenetic analysis, as well as combining the transcriptome and metabolome data from different developmental stages of <em>G. lucidum</em>, candidate <em>GlbHLHs</em> were screened. Subsequently, their regulatory roles in ganoderic acid biosynthesis were explored using yeast one-hybrid and dual-luciferase reporter assays.</div></div><div><h3>Results</h3><div>A total of 11 <em>GlbHLH</em> members were characterized in <em>G. lucidum</em>. The upstream promoter regions of these genes enriched hormones and abiotic stress responsive elements. Although individual ganoderic acid monomers demonstrated marked differences in accumulation patterns across specific growth phases and tissue types, overall, the total GA content was consistently higher in caps than in stipes throughout development. In addition, all <em>GlbHLH</em>s exhibited high expression in whole <em>G. lucidum</em> from the primordium to maturation stages. Among them, <em>GlbHLH5</em> and <em>GlbHLH7</em> showed the highest expression in any stage and highly correlated with key genes associated with GA pathway. Functional validation through dual-luciferase assays and yeast one-hybrid experiments had demonstrated that <em>GlbHLH5</em> activated the P2 region of the lanosterol synthase promoter, while <em>GlbHLH7</em> activated the promoters of squalene epoxidase and squalene synthase.</div></div><div><h3>Conclusion</h3><div>Compared to plants, <em>G. lucidum</em> harbored a small number of <em>bHLH</em> members but all high expression in any stages. Additionally, <em>GlbHLH5</em> and <em>GlbHLH7</em> with the highest expression among <em>GlbHLHs</em> showed activation in regulating the biosynthesis of GA. These results provide a theoretical reference for further research on ganoderic acid regulation in <em>G. lucidum</em>, and thereby providing a molecular foundation for enhancing ganoderic acid yield to optimize the medicinal value of <em>G. lucidum.</em></div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 200-211"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.03.004
Wen Liu , Biqiong Zhang , Zhengxi Hu , Si Yao , Yunpeng Zhao , Fengqing Wang , Yuanyuan Wang , Xinxin Yang , Jie Yin , Weiguang Sun , Qingyi Tong , Lianghu Gu , Yonghui Zhang
Objective
To design and synthesize an amount of butyrolactone V derivatives, evaluate the anti-inflammatory effects of all the derivatives, look for potential drugs that inhibit inflammatory bowel disease (IBD), and determine the structure-activity relationship (SAR).
Methods
The butyrolactone V derivatives were synthesized with high yield by oxidation reaction, substitution reaction, and esterification reaction in sequence, and the production of nitric oxide was assessed in RAW264.7 cells treated with the lipopolysaccharide and the compounds. Then, the target compounds were studied for their activity in dextran sodium sulfate (DSS)-induced ulcerative colitis.
Results
A total of three series of compounds encompassing 60 derivatives of the natural product butyrolactone V were designed and synthesized. The results showed that compounds 5p and 7e could alleviate the symptoms of DSS-induced colitis in mice, including alleviating diarrhea, inhibiting the reduction of colon length, and reducing tissue damage. The preliminary mechanism exploration indicated that compounds 5p and 7e could improve the symptoms of IBD in mice mainly by reducing the expression of chemokines and exerting anti-inflammatory effects.
Conclusion
This study reports the synthesis and the derivatization of butyrolactone V and analysis on anti-inflammatory activity. The most effective compounds 5p and 7e have the potential to be further developed as drugs to treat IBD.
{"title":"Design and synthesis of butyrolactone V derivatives and its anti-inflammatory activity analysis","authors":"Wen Liu , Biqiong Zhang , Zhengxi Hu , Si Yao , Yunpeng Zhao , Fengqing Wang , Yuanyuan Wang , Xinxin Yang , Jie Yin , Weiguang Sun , Qingyi Tong , Lianghu Gu , Yonghui Zhang","doi":"10.1016/j.chmed.2025.03.004","DOIUrl":"10.1016/j.chmed.2025.03.004","url":null,"abstract":"<div><h3>Objective</h3><div>To design and synthesize an amount of butyrolactone V derivatives, evaluate the anti-inflammatory effects of all the derivatives, look for potential drugs that inhibit inflammatory bowel disease (IBD), and determine the structure-activity relationship (SAR).</div></div><div><h3>Methods</h3><div>The butyrolactone V derivatives were synthesized with high yield by oxidation reaction, substitution reaction, and esterification reaction in sequence, and the production of nitric oxide was assessed in RAW264.7 cells treated with the lipopolysaccharide and the compounds. Then, the target compounds were studied for their activity in dextran sodium sulfate (DSS)-induced ulcerative colitis.</div></div><div><h3>Results</h3><div>A total of three series of compounds encompassing 60 derivatives of the natural product butyrolactone V were designed and synthesized. The results showed that compounds <strong>5p</strong> and <strong>7e</strong> could alleviate the symptoms of DSS-induced colitis in mice, including alleviating diarrhea, inhibiting the reduction of colon length, and reducing tissue damage. The preliminary mechanism exploration indicated that compounds <strong>5p</strong> and <strong>7e</strong> could improve the symptoms of IBD in mice mainly by reducing the expression of chemokines and exerting anti-inflammatory effects.</div></div><div><h3>Conclusion</h3><div>This study reports the synthesis and the derivatization of butyrolactone V and analysis on anti-inflammatory activity. The most effective compounds <strong>5p</strong> and <strong>7e</strong> have the potential to be further developed as drugs to treat IBD.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 142-152"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.11.002
Mengyue Wang , Haotian Wu , Li Xiang , Ranran Gao , Qinggang Yin , Yang Chu , Lan Wu , Yanyan Su , Gangqiang Dong , Yuhua Shi
As the only naturally occurring stable derivative of L-ascorbic acid (AA; vitamin C), 2-O-β-D-glucopyranosyl-L-ascorbic acid (AA-2βG) is hydrolyzed in vivo to release active AA. AA-2βG exhibits strong antioxidant and antiphotoaging effects comparable to those of AA, and it plays a key role in maintaining organismal health. Owing to its superior stability and bioavailability, AA-2βG is considered as a promising, longer-lasting natural alternative to conventional vitamin C. It was first identified and is particularly abundant in Lycii Fructus (Gouqizi in Chinese) but has been detected in several crop plants. This review offers a comprehensive overview of recent advances in AA-2βG research, covering key aspects including discovery, structure, natural sources, extraction and detection methods, chemical and in vitro enzymatic synthesis, biosynthetic pathways, as well as applications in health care, skin care, and functional foods. Additionally, we highlight strategies for leveraging plant resources and enhancing AA-2βG biosynthesis, which are expected to accelerate future research and support the sustainable development and utilization of AA-2βG and other high-value natural products.
作为l-抗坏血酸(AA;维生素C)唯一天然存在的稳定衍生物,2-O-β- d -葡萄糖吡喃基- l-抗坏血酸(AA-2β g)在体内水解释放出活性AA。AA-2β g具有与AA相当的抗氧化和抗光老化作用,在维持机体健康中起关键作用。由于其优越的稳定性和生物利用度,AA-2βG被认为是一种有前途的、持久的天然维生素c替代品。它最早被发现,在枸杞子中含量特别丰富,但在几种作物植物中也被检测到。本文综述了AA-2βG的发现、结构、天然来源、提取和检测方法、化学和体外酶合成、生物合成途径以及在保健、护肤和功能食品中的应用等方面的研究进展。此外,我们还强调了利用植物资源和促进AA-2βG生物合成的策略,以期加快未来的研究,并支持AA-2βG和其他高价值天然产物的可持续开发和利用。
{"title":"Natural novel vitamin C derivative, 2-O-β-D-glucopyranosyl-L-ascorbic acid: Resources, biosynthesis, and applications","authors":"Mengyue Wang , Haotian Wu , Li Xiang , Ranran Gao , Qinggang Yin , Yang Chu , Lan Wu , Yanyan Su , Gangqiang Dong , Yuhua Shi","doi":"10.1016/j.chmed.2025.11.002","DOIUrl":"10.1016/j.chmed.2025.11.002","url":null,"abstract":"<div><div>As the only naturally occurring stable derivative of <em>L-</em>ascorbic acid (AA; vitamin C), 2-<em>O</em>-<em>β</em>-<em>D</em>-glucopyranosyl-<em>L</em>-ascorbic acid (AA-2<em>β</em>G) is hydrolyzed <em>in vivo</em> to release active AA. AA-2<em>β</em>G exhibits strong antioxidant and antiphotoaging effects comparable to those of AA, and it plays a key role in maintaining organismal health. Owing to its superior stability and bioavailability, AA-2<em>β</em>G is considered as a promising, longer-lasting natural alternative to conventional vitamin C. It was first identified and is particularly abundant in <em>Lycii Fructus</em> (Gouqizi in Chinese) but has been detected in several crop plants. This review offers a comprehensive overview of recent advances in AA-2<em>β</em>G research, covering key aspects including discovery, structure, natural sources, extraction and detection methods, chemical and <em>in vitro</em> enzymatic synthesis, biosynthetic pathways, as well as applications in health care, skin care, and functional foods. Additionally, we highlight strategies for leveraging plant resources and enhancing AA-2<em>β</em>G biosynthesis, which are expected to accelerate future research and support the sustainable development and utilization of AA-2<em>β</em>G and other high-value natural products.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 77-88"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.11.004
Keqian Li , Fangyu Xiang , Xin Yang , Mengqi Liu , Rui Long , Li Han , Ming Yang , Dingkun Zhang , Yanan He
Indirubin (IND), a bisindole alkaloid with remarkable pharmacological activities, has attracted significant attention in the pharmaceutical field due to its antileukemic, anti-inflammatory, and immunomodulatory properties. Currently, indirubin primarily relies on plant extraction and chemical synthesis, which are hindered by complex processes, low yields, and poor environmental compatibility. These challenges pose serious obstacles to clinical supply and sustainable industrial development. In recent years, microbial synthesis technology, which is based on synthetic biology and metabolic engineering, has provided a novel approach for the efficient production of indirubin. This method offers several advantages, including high efficiency, environmental sustainability, and eco-friendliness. Hence, this manuscript systematically summarizes the biosynthesis mechanisms of indirubin, the catalytic characteristics of key enzymes, the construction strategies of engineered bacteria, and the progress in fermentation condition. To address challenges such as the difficult separation of indirubin isomers, by-product inhibition, and industrialization bottlenecks, potential solutions are proposed, aiming to promote the green biomanufacturing of indirubin.
{"title":"Advances in microbial biosynthesis of indirubin","authors":"Keqian Li , Fangyu Xiang , Xin Yang , Mengqi Liu , Rui Long , Li Han , Ming Yang , Dingkun Zhang , Yanan He","doi":"10.1016/j.chmed.2025.11.004","DOIUrl":"10.1016/j.chmed.2025.11.004","url":null,"abstract":"<div><div>Indirubin (IND), a bisindole alkaloid with remarkable pharmacological activities, has attracted significant attention in the pharmaceutical field due to its antileukemic, anti-inflammatory, and immunomodulatory properties. Currently, indirubin primarily relies on plant extraction and chemical synthesis, which are hindered by complex processes, low yields, and poor environmental compatibility. These challenges pose serious obstacles to clinical supply and sustainable industrial development. In recent years, microbial synthesis technology, which is based on synthetic biology and metabolic engineering, has provided a novel approach for the efficient production of indirubin. This method offers several advantages, including high efficiency, environmental sustainability, and eco-friendliness. Hence, this manuscript systematically summarizes the biosynthesis mechanisms of indirubin, the catalytic characteristics of key enzymes, the construction strategies of engineered bacteria, and the progress in fermentation condition. To address challenges such as the difficult separation of indirubin isomers, by-product inhibition, and industrialization bottlenecks, potential solutions are proposed, aiming to promote the green biomanufacturing of indirubin.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 45-58"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.03.007
Wei Wu , Djibril Bamba , Zheng Zhang , Feng Wu , Yuan Li , Wenyi Qi , Yingzhe Liu , Tingting Zhang , Ying Su , Xinyue Wang , Hongbo Wang , Shuqin Duan , Jingwen Ne , Wenbo Wang , Jingwei Liu , Jianyong Tang , Fengda Li , Qingchao Wu , Yang Li , Fan Yang , Lei Yang
Objective
Arsenic trioxide (ATO) is a clinically effective anticancer agent used in the treatment of leukemia. However, it exerts adverse effects on non-tumor cells, including bone marrow mesenchymal stem cells (BMSCs). This study aims to investigate the protective role and molecular mechanism of traditional Chinese medicine Astragalus polysaccharides (APS) in mitigating ATO-induced apoptosis in BMSCs.
Methods
BMSCs exposed to ATO (0.5 μmol/L) were treated with APS (20, 40, 100, and 200 μg/mL). Cell viability, proliferation, and migration were assessed by using MTT, EdU staining, Transwell, and scratch wound healing assays. Apoptosis was evaluated via TUNEL assay, Hoechst 33258 staining, and flow cytometry. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential were measured by using DCFH-DA and JC-1 staining. Apoptotic protein expression was analyzed by Western blotting.
Results
ATO exposure significantly inhibited the proliferation and migration of BMSCs and induced apoptosis, while APS markedly attenuated the apoptosis of BMSCs induced by ATO, and significantly improved cell proliferation and migration (P < 0.01). Mechanistically, APS effectively reduced ATO-induced ROS (P < 0.01), while the protein expression of Bcl-2-associated X protein (Bax) and cleaved Caspase-3 was significantly decreased (P < 0.05), and the protein expression of Bcl-2 was significantly increased (P < 0.01). In addition, APS markedly decreased the protein expression of c-Jun N-terminal kinase (Jnk) and p38 in ATO-activated BMSCs (P < 0.05), and significantly decreased the protein expression of p16 and p53 (P < 0.01), and increased the protein expression of phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-Erk) (P < 0.01, 0.05).
Conclusion
Our study reveals that APS exert significant protective effects against ATO-induced apoptosis in BMSCs. The mechanisms involve suppressing ROS generation, maintaining mitochondrial membrane stability, enhancing cell viability, migration, and proliferation, as well as inhibiting Jnk and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways. The findings highlight potential molecular targets and novel strategies for the clinical prevention and treatment of ATO-related toxicity.
{"title":"Astragalus polysaccharides inhibit arsenic trioxide-induced BMSCs damage through inhibition of Jnk and p38 signaling pathways","authors":"Wei Wu , Djibril Bamba , Zheng Zhang , Feng Wu , Yuan Li , Wenyi Qi , Yingzhe Liu , Tingting Zhang , Ying Su , Xinyue Wang , Hongbo Wang , Shuqin Duan , Jingwen Ne , Wenbo Wang , Jingwei Liu , Jianyong Tang , Fengda Li , Qingchao Wu , Yang Li , Fan Yang , Lei Yang","doi":"10.1016/j.chmed.2025.03.007","DOIUrl":"10.1016/j.chmed.2025.03.007","url":null,"abstract":"<div><h3>Objective</h3><div>Arsenic trioxide (ATO) is a clinically effective anticancer agent used in the treatment of leukemia. However, it exerts adverse effects on non-tumor cells, including bone marrow mesenchymal stem cells (BMSCs). This study aims to investigate the protective role and molecular mechanism of traditional Chinese medicine Astragalus polysaccharides (APS) in mitigating ATO-induced apoptosis in BMSCs.</div></div><div><h3>Methods</h3><div>BMSCs exposed to ATO (0.5 μmol/L) were treated with APS (20, 40, 100, and 200 μg/mL). Cell viability, proliferation, and migration were assessed by using MTT, EdU staining, Transwell, and scratch wound healing assays. Apoptosis was evaluated via TUNEL assay, Hoechst 33258 staining, and flow cytometry. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential were measured by using DCFH-DA and JC-1 staining. Apoptotic protein expression was analyzed by Western blotting.</div></div><div><h3>Results</h3><div>ATO exposure significantly inhibited the proliferation and migration of BMSCs and induced apoptosis, while APS markedly attenuated the apoptosis of BMSCs induced by ATO, and significantly improved cell proliferation and migration (<em>P</em> < 0.01). Mechanistically, APS effectively reduced ATO-induced ROS (<em>P</em> < 0.01), while the protein expression of Bcl-2-associated X protein (Bax) and cleaved Caspase-3 was significantly decreased (<em>P</em> < 0.05), and the protein expression of Bcl-2 was significantly increased (<em>P</em> < 0.01). In addition, APS markedly decreased the protein expression of c-Jun <em>N</em>-terminal kinase (Jnk) and p38 in ATO-activated BMSCs (<em>P</em> < 0.05), and significantly decreased the protein expression of p16 and p53 (<em>P</em> < 0.01), and increased the protein expression of phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-Erk) (<em>P</em> < 0.01, 0.05).</div></div><div><h3>Conclusion</h3><div>Our study reveals that APS exert significant protective effects against ATO-induced apoptosis in BMSCs. The mechanisms involve suppressing ROS generation, maintaining mitochondrial membrane stability, enhancing cell viability, migration, and proliferation, as well as inhibiting Jnk and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways. The findings highlight potential molecular targets and novel strategies for the clinical prevention and treatment of ATO-related toxicity<strong><em>.</em></strong></div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 178-187"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.11.003
Chenhao Jia , Junying Ma , Lingli Fang , Huanzi Guo , Meiling Ding , Yishuang Wang , Renxiang Tan
Objective
Plant-derived terpenoid ginkgolides exhibit significant pharmacological efficacy, however, their extraction remains costly. Given that levopimaradiene is a key biosynthetic precursor to ginkgolides, its high-yield production via heterologous gene expression therefore establishes a critical foundation for scaling up their manufacture. This study primarily aims to enhance the yield of levopimaradiene in Escherichia coli (LB medium) by remodeling the unnatural isopentenol utilization pathway (IUP).
Methods
Plasmid construction was driven by the mechanism of homologous recombination, which utilizes recombinase to facilitate the ligation process. The expression of kinase was carried out using type 7 (T7) promoter and isopropyl β-D-1-thiogalactopyranoside (IPTG) as the inducer. The quantification of levopimaradiene produced by E. coli was determined by comparison with a standard curve that we constructed.
Results
Combining the selection of kinases, ribosome-binding site (RBS) screening, protein directed evolution and optimization of fermentation parameters, the production of levopimaradiene in E. coli was ultimately enhanced to 2691.3 mg/L, surpassing the highest reported titers of levopimaradiene with 6-fold in E. coli to date. Additionally, the engineered E. coli was designed to collaborate with farnesyl pyrophosphate (FPP) synthase and geranylfarnesyl pyrophosphate (GFPP) synthase to efficiently produce FPP and GFPP for sesquiterpene and sesterterpene synthesis.
Conclusion
Our work showcases a combinatorial engineering strategy that employs an IUP-enhanced E. coli chassis for the microbial production of levopimaradiene, as well as other natural terpenoids.
目的植物源性萜类银杏内酯具有显著的药理作用,但其提取成本较高。鉴于左旋马二烯是银杏内酯的关键生物合成前体,因此通过异源基因表达的高产量生产为扩大银杏内酯的生产规模奠定了重要基础。本研究主要目的是通过重塑非自然异戊烯醇利用途径(IUP),提高大肠杆菌(LB培养基)中左旋马二烯的产率。方法利用同源重组机制,利用重组酶促进连接过程,构建asmid。以7型启动子(T7)和异丙基β- d -1-硫代半乳糖苷(IPTG)为诱导剂进行激酶的表达。通过与我们构建的标准曲线比较,确定了大肠杆菌产生的左旋马二烯的定量。结果结合激酶选择、核糖体结合位点筛选、蛋白定向进化和发酵参数优化,最终使大肠杆菌的左旋马二烯产量提高到2691.3 mg/L,是迄今为止报道的大肠杆菌左旋马二烯滴度的6倍。此外,设计的工程大肠杆菌与法尼基焦磷酸(FPP)合成酶和香叶基法尼基焦磷酸(GFPP)合成酶协同高效生产FPP和GFPP,用于倍半萜和二萜的合成。我们的工作展示了一种组合工程策略,该策略采用iop增强的大肠杆菌底盘,用于微生物生产左旋马二烯和其他天然萜类。
{"title":"Enhancement of levopimaradiene production in Escherichia coli via engineering isopentenol utilization pathway","authors":"Chenhao Jia , Junying Ma , Lingli Fang , Huanzi Guo , Meiling Ding , Yishuang Wang , Renxiang Tan","doi":"10.1016/j.chmed.2025.11.003","DOIUrl":"10.1016/j.chmed.2025.11.003","url":null,"abstract":"<div><h3>Objective</h3><div>Plant-derived terpenoid ginkgolides exhibit significant pharmacological efficacy, however, their extraction remains costly. Given that levopimaradiene is a key biosynthetic precursor to ginkgolides, its high-yield production via heterologous gene expression therefore establishes a critical foundation for scaling up their manufacture. This study primarily aims to enhance the yield of levopimaradiene in <em>Escherichia coli</em> (LB medium) by remodeling the unnatural isopentenol utilization pathway (IUP).</div></div><div><h3>Methods</h3><div>Plasmid construction was driven by the mechanism of homologous recombination, which utilizes recombinase to facilitate the ligation process. The expression of kinase was carried out using type 7 (T7) promoter and isopropyl <em>β</em>-<em>D</em>-1-thiogalactopyranoside (IPTG) as the inducer. The quantification of levopimaradiene produced by E. coli was determined by comparison with a standard curve that we constructed.</div></div><div><h3>Results</h3><div>Combining the selection of kinases, ribosome-binding site (RBS) screening, protein directed evolution and optimization of fermentation parameters, the production of levopimaradiene in <em>E. coli</em> was ultimately enhanced to 2691.3 mg/L, surpassing the highest reported titers of levopimaradiene with 6-fold in <em>E. coli</em> to date. Additionally, the engineered <em>E. coli</em> was designed to collaborate with farnesyl pyrophosphate (FPP) synthase and geranylfarnesyl pyrophosphate (GFPP) synthase to efficiently produce FPP and GFPP for sesquiterpene and sesterterpene synthesis.</div></div><div><h3>Conclusion</h3><div>Our work showcases a combinatorial engineering strategy that employs an IUP-enhanced <em>E. coli</em> chassis for the microbial production of levopimaradiene, as well as other natural terpenoids.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 89-96"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2024.06.003
Wenjing Li , Yuan Gao , Jingjing Yan, Min Cai, Chenchen Zang, Zhuangzhuang Liu, Ximeng Li, Runlan Cai, Yun Qi
Objective
Xuebijing Injection (XBJI) is mainly used for treating sepsis in China, and even COVID-19 recently. This study aimed to clarify the molecular mechanism(s) and identify the potential “common culprit(s)” for XBJI-caused immediate hypersensitivity reaction (IHR) which is the main type of its adverse reactions.
Methods
Antiserum against XBJI was prepared by intraperitoneal immunization in combination with aluminum adjuvant for five weeks. Antagonistic experiments were performed by using several antagonists against different mediators in Evans Blue leakage model. Propranolol-pretreated mice were used to determine the capacity of XBJI to trigger systemic IHR. Serum total IgE (tIgE) and mouse mast cell protease 1 (MCPT-1) levels, complement activation, and the levels of supernatant inflammatory mediators were determined by ELISAs. Lipopolysaccharide (LPS)-activated RAW264.7 macrophages were used for evaluating the anti-inflammatory activity of XBJI, while human mast cells (LAD2) were used for assessing the effect of XBJI on mast cell degranulation.
Results
Continuous treatment (i.p.) with XBJI along with aluminum adjuvant did not elevate the levels of serum tIgE and MCPT-1. In vitro, XBJI could not directly cause the degranulation of LAD2 cells. It induced a robust Evans Blue leakage after the first injection in mouse paw. Mechanism study demonstrated that antagonists for histamine H1/H2 receptors and complement C3a receptor counteracted XBJI-induced IHR. XBJI also directly activated complement C3 in human serum. Through screening five herbs of XBJI and the constituents, only safflower yellow (SY) in Carthami Flos was able to induce IHR. The discolored-XBJI not only did not induce IHR locally and systemically, but also could suppressing the production of proinflammatory mediators in LPS-activated RAW264.7 macrophages.
Conclusion
XBJI failed to induce immune IHR, but potently triggered non-immune IHR through direct activating complement C3 to provoke histamine release. SY in Carthami Flos was the underlying “common culprit” responsible for XBJI-caused IHR. The anti-inflammatory action of XBJI can be retained after decolorization. Our study provides a scientific basis for not only preventing and treating XBJI-caused IHR clinically, but also improving its production process.
{"title":"Safflower yellow in Carthami Flos is responsible for Xuebijing Injection-induced immediate hypersensitivity reaction through activating complement C3","authors":"Wenjing Li , Yuan Gao , Jingjing Yan, Min Cai, Chenchen Zang, Zhuangzhuang Liu, Ximeng Li, Runlan Cai, Yun Qi","doi":"10.1016/j.chmed.2024.06.003","DOIUrl":"10.1016/j.chmed.2024.06.003","url":null,"abstract":"<div><h3>Objective</h3><div>Xuebijing Injection (XBJI) is mainly used for treating sepsis in China, and even COVID-19 recently. This study aimed to clarify the molecular mechanism(s) and identify the potential “common culprit(s)” for XBJI-caused immediate hypersensitivity reaction (IHR) which is the main type of its adverse reactions.</div></div><div><h3>Methods</h3><div>Antiserum against XBJI was prepared by intraperitoneal immunization in combination with aluminum adjuvant for five weeks. Antagonistic experiments were performed by using several antagonists against different mediators in Evans Blue leakage model. Propranolol-pretreated mice were used to determine the capacity of XBJI to trigger systemic IHR. Serum total IgE (tIgE) and mouse mast cell protease 1 (MCPT-1) levels, complement activation, and the levels of supernatant inflammatory mediators were determined by ELISAs. Lipopolysaccharide (LPS)-activated RAW264.7 macrophages were used for evaluating the anti-inflammatory activity of XBJI, while human mast cells (LAD2) were used for assessing the effect of XBJI on mast cell degranulation.</div></div><div><h3>Results</h3><div>Continuous treatment (<em>i.p.</em>) with XBJI along with aluminum adjuvant did not elevate the levels of serum tIgE and MCPT-1. <em>In vitro</em>, XBJI could not directly cause the degranulation of LAD2 cells. It induced a robust Evans Blue leakage after the first injection in mouse paw. Mechanism study demonstrated that antagonists for histamine H1/H2 receptors and complement C3a receptor counteracted XBJI-induced IHR. XBJI also directly activated complement C3 in human serum. Through screening five herbs of XBJI and the constituents, only safflower yellow (SY) in <em>Carthami Flos</em> was able to induce IHR. The discolored-XBJI not only did not induce IHR locally and systemically, but also could suppressing the production of proinflammatory mediators in LPS-activated RAW264.7 macrophages.</div></div><div><h3>Conclusion</h3><div>XBJI failed to induce immune IHR, but potently triggered non-immune IHR through direct activating complement C3 to provoke histamine release. SY in <em>Carthami Flos</em> was the underlying “common culprit” responsible for XBJI-caused IHR. The anti-inflammatory action of XBJI can be retained after decolorization. Our study provides a scientific basis for not only preventing and treating XBJI-caused IHR clinically, but also improving its production process.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 188-199"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.02.009
Ruiting Liu , Nuo Xu , Xuejiao Song , Yanying Li , Jie Bu , Runtao Su , Hong Guo , Chen Jiang , Pengwei Zhuang , Yanjun Zhang , Qingsheng Yin
Diabetes involves multi-organ complications that seriously threaten human life and health, and has become a major public health problem of global concern. Unfortunately, clinical management strategies for diabetic complications are still in their “infancy”, restricted by a limited understanding of their complex pathological mechanism. As is well established, lipid metabolism disorder is the characteristic pathological factors of diabetes, but the detailed molecular mechanisms driving the progression of multi-organ complications remain obscure. Protein S-acylation (often referred to as S-palmitoylation) is a reversible lipid modification that reversibly binds fatty acids to protein-specific cysteine (Cys) residues through palmitoyl acyl transferases (PATs, also known as DHHCs) and deacylation enzymes, which is involved in the pathological progression of a variety of complex diseases such as cancer, neurological disorders and metabolic syndrome. Notably, recent studies have shown that protein S-acylation drives the progression of diabetes and its multiple complications, and targeted intervention in the protein S-acylation process significantly alleviates the progression of diabetes and its complications, suggesting that protein S-acylation may be a common pathological link and intervention target of diabetes complications. Therefore, this review systematically comprehends the contribution of protein S-acylation to the progression of diabetes and its complications, summarizes the influence of the diabetic environment on S-acylation related enzymes, as well as providing an in-depth analysis of current drugs, measures, and challenges in targeting S-acylation. Finally, the accessibility of targeting protein S-acylation to prevent diabetes and its complications and the focus of future in-depth studies are envisioned, with a view to providing comprehensive and in-depth references and rationale for future novel strategies targeting protein S-acylation to prevent and treat diabetes and its multi-organ complications.
{"title":"Protein S-acylation: Pathological mechanisms and novel therapeutic targets for diabetic complications","authors":"Ruiting Liu , Nuo Xu , Xuejiao Song , Yanying Li , Jie Bu , Runtao Su , Hong Guo , Chen Jiang , Pengwei Zhuang , Yanjun Zhang , Qingsheng Yin","doi":"10.1016/j.chmed.2025.02.009","DOIUrl":"10.1016/j.chmed.2025.02.009","url":null,"abstract":"<div><div>Diabetes involves multi-organ complications that seriously threaten human life and health, and has become a major public health problem of global concern. Unfortunately, clinical management strategies for diabetic complications are still in their “infancy”, restricted by a limited understanding of their complex pathological mechanism. As is well established, lipid metabolism disorder is the characteristic pathological factors of diabetes, but the detailed molecular mechanisms driving the progression of multi-organ complications remain obscure. Protein S-acylation (often referred to as S-palmitoylation) is a reversible lipid modification that reversibly binds fatty acids to protein-specific cysteine (Cys) residues through palmitoyl acyl transferases (PATs, also known as DHHCs) and deacylation enzymes, which is involved in the pathological progression of a variety of complex diseases such as cancer, neurological disorders and metabolic syndrome. Notably, recent studies have shown that protein S-acylation drives the progression of diabetes and its multiple complications, and targeted intervention in the protein S-acylation process significantly alleviates the progression of diabetes and its complications, suggesting that protein S-acylation may be a common pathological link and intervention target of diabetes complications. Therefore, this review systematically comprehends the contribution of protein S-acylation to the progression of diabetes and its complications, summarizes the influence of the diabetic environment on S-acylation related enzymes, as well as providing an in-depth analysis of current drugs, measures, and challenges in targeting S-acylation. Finally, the accessibility of targeting protein S-acylation to prevent diabetes and its complications and the focus of future in-depth studies are envisioned, with a view to providing comprehensive and in-depth references and rationale for future novel strategies targeting protein S-acylation to prevent and treat diabetes and its multi-organ complications.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 110-123"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.chmed.2025.11.008
Jing Wang , Jingyuan Song , Shilin Chen , Zhichao Xu
Medicinal plants synthesize structurally diverse pharmacologically active natural products through conserved precursor pathways, which are further diversified by lineage-specific tailoring enzymes. Although the biosynthetic pathways of well-studied compounds (e.g., berberine, paclitaxel, and ginsenosides) have been extensively characterized, most bioactive components in Traditional Chinese Medicine (TCM) remain poorly understood. The emerging discipline of Herbgenomics has significantly advanced biosynthetic gene discovery and pathway elucidation. By employing genomics-driven strategies such as biosynthetic gene cluster mining, co-expression analysis, and integrated transcriptome-metabolome profiling, Herbgenomics enables systematic identification of key biosynthetic enzymes and uncovers evolutionary mechanisms (e.g., whole-genome and tandem gene duplications) driving metabolic innovation. Furthermore, it provides a foundation for drug development by leveraging gene-encoded natural diverse components and genome-wide pan-receptor platforms (e.g., pan-GPCR). Through the integration of pathway analysis, regulatory mechanisms, molecular breeding, and synthetic biology, Herbgenomics establishes a comprehensive framework for exploring and engineering TCM natural product biosynthesis, offering a sustainable pathway to the discovery and production of bioactive compounds.
{"title":"Herbgenomics: Unraveling natural product biosynthesis in traditional Chinese medicine","authors":"Jing Wang , Jingyuan Song , Shilin Chen , Zhichao Xu","doi":"10.1016/j.chmed.2025.11.008","DOIUrl":"10.1016/j.chmed.2025.11.008","url":null,"abstract":"<div><div>Medicinal plants synthesize structurally diverse pharmacologically active natural products through conserved precursor pathways, which are further diversified by lineage-specific tailoring enzymes. Although the biosynthetic pathways of well-studied compounds (e.g., berberine, paclitaxel, and ginsenosides) have been extensively characterized, most bioactive components in Traditional Chinese Medicine (TCM) remain poorly understood. The emerging discipline of Herbgenomics has significantly advanced biosynthetic gene discovery and pathway elucidation. By employing genomics-driven strategies such as biosynthetic gene cluster mining, co-expression analysis, and integrated transcriptome-metabolome profiling, Herbgenomics enables systematic identification of key biosynthetic enzymes and uncovers evolutionary mechanisms (e.g., whole-genome and tandem gene duplications) driving metabolic innovation. Furthermore, it provides a foundation for drug development by leveraging gene-encoded natural diverse components and genome-wide pan-receptor platforms (e.g., pan-GPCR). Through the integration of pathway analysis, regulatory mechanisms, molecular breeding, and synthetic biology, Herbgenomics establishes a comprehensive framework for exploring and engineering TCM natural product biosynthesis, offering a sustainable pathway to the discovery and production of bioactive compounds.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 3-10"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}